Investors love dividend stocks, especially high-yield varieties, because they offer a significant income stream and have substantial total return potential.
Most dividend checks arrive only four times a year, which means investors who live off the income are forced to budget every three months.
Just when investors thought this time just might be different, volatility came back in the door. A few words from Federal Reserve Chair Jerome Powell and heavier-than-expected capital expenditure guidance from some of the key hyperscalers stopped the stock rally in its tracks.
Healthpeak Properties is paying out a 6.5% dividend yield that was 151% covered by its FFO during the third quarter. The REIT saw third-quarter renewal cash-releasing spreads on its Outpatient Medical segment move up by 5.4%, with Lab advancing by 4.6%. DOC most recently issued debt at a low spread of just 75 basis points to the current U.S. 10-year Treasury yield, while trading on its lowest multiple to cash flow.
DOC's third-quarter results reflect the continued strong performance of its high-quality outpatient medical and CCRC portfolios.
Although the revenue and EPS for Healthpeak (DOC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.46 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to FFO of $0.45 per share a year ago.
Healthpeak Properties is a diversified healthcare REIT with a strong tenant mix, robust financials, and a 6.3% monthly dividend yield. DOC benefits from merger synergies, AFFO per share growth, and decent balance sheet management, positioning it well for an improving macro environment. Rate cuts and lower treasury yields are key near-term catalysts, while fundamentals support DOC for further dividend increases.
I'm expanding my portfolio with undervalued REITs like Healthpeak Properties, aiming to capitalize on market overreactions and irrational selling. Healthpeak's valuation is disconnected from its fundamentals; current market pessimism doesn't reflect the cyclical nature of real estate supply and demand. Healthpeak's disciplined capital allocation, including selective buybacks and reinvestment, reflects prudent management in a volatile rate environment.
Healthpeak Properties trades at a deep discount, with limited downside risk and a well-covered 6.9% dividend yield. The balance sheet is strong, with net debt/EBITDAre at 5.2x and $2.3 billion in liquidity. Valuation is driven by lab space concerns, despite lab space being only 40% of its portfolio, whereas its medical office and senior housing segments remain stable.
Healthpeak Properties, Inc. (NYSE:DOC ) Q2 2025 Earnings Conference Call July 25, 2025 10:00 AM ET Company Participants Andrew Johns - Senior Vice President of Investor Relations Kelvin O. Moses - Chief Financial Officer Mark Theine - Corporate Participant Scott M.
DOC's second-quarter results reflect the continued strong performance of its high-quality lab, outpatient medical and CCRC portfolios.